Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss drug.

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how ...

But what is important to me is transparency.” That calling has led her to this very moment: Williams is ready to share that ...

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to "align with federal coverage requirements." ...

Serena Williams revealed she uses GLP-1 medication to aid weight loss after motherhood. This highlights a shift towards combining medicine with lifestyle for obesity management.

GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...

Serena Williams is getting real about her weight-loss journey. Since April, the retired tennis legend has been on a GLP-1 ...

GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...